PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) announced that it received FDA approval for its ketamine product KETARx on August ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE